Related Experiment Video
Updated: Sep 9, 2025

Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
Advances in therapeutic strategies for acute kidney injury
Shuangyan Song1, Wuyue Su2, Hongbo Wang1
1School of Pharmacy, Key Laboratory of Molecular Pharmacology and Drug Evaluation (Yantai University), Ministry of Education, Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong, Yantai University, Yantai 264005, China.
Abstract:
Acute Kidney Injury (AKI) is a complex clinical syndrome marked by a rapid decline in renal function, most commonly triggered by ischemia, hypoxia, or nephrotoxic insults, and is associated with significant morbidity and mortality. Despite advances in understanding its underlying mechanisms, current treatments remain predominantly supportive, with no effective therapies available to reverse or repair renal damage. Although biomarker-guided precision medicine holds promise, its clinical utility requires further validation through large-scale trials. This review summarizes recent progress in AKI therapy, with a particular focus on injury induced by nephrotoxic drugs (cisplatin, aminoglycosides, contrast media), sepsis, and ischemia-reperfusion. It discusses innovative strategies including nanomedicine-based drug delivery, plant-derived therapeutics, ferroptosis inhibition, and gene or microRNA-targeted approaches, alongside emerging clinical interventions and assessment tools. By bridging experimental findings with clinical application, this review provides insight into evolving therapeutic avenues and emphasizes the ongoing need for targeted, effective interventions to improve outcomes in AKI.
Insights
Acute Kidney Injury (AKI) treatments are limited, with supportive care being the norm. This review explores novel therapeutic strategies, including nanomedicine and gene therapy, to repair kidney damage.
Area of Science:
- Nephrology
- Translational Medicine
- Pharmacology
Background:
- Acute Kidney Injury (AKI) is a critical condition with high mortality.
- Current AKI treatments are primarily supportive, lacking effective renal repair therapies.
- Understanding AKI mechanisms is advancing, but clinical interventions lag.
Purpose of the Study:
- To review recent advancements in Acute Kidney Injury (AKI) therapy.
- To focus on AKI induced by nephrotoxic drugs, sepsis, and ischemia-reperfusion.
- To highlight innovative therapeutic strategies and emerging clinical tools.
Main Methods:
- Literature review of recent progress in AKI therapy.
- Focus on specific AKI causes: nephrotoxic drugs, sepsis, ischemia-reperfusion.
- Discussion of novel approaches: nanomedicine, plant-derived therapeutics, ferroptosis inhibition, gene/microRNA targeting.
Main Results:
- Several innovative therapeutic strategies show promise for AKI.
- Nanomedicine, plant-derived compounds, ferroptosis inhibitors, and gene-based therapies are emerging.
- New clinical interventions and assessment tools are under development.
Conclusions:
- Effective therapies to reverse or repair AKI remain a critical unmet need.
- Innovative strategies like nanomedicine and gene therapy offer potential for AKI treatment.
- Bridging experimental research and clinical application is crucial for improving AKI outcomes.
Related Concept Videos
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury III: Clinical Manifestations

